Release of proinflammatory cytokines during pediatric cardiopulmonary bypass: heparin-bonded versus nonbonded oxygenators.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Annals of Thoracic Surgery

• Publication date

  1997-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0003-4975(97)00846-1PMID 9436574
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Complement activation and bioincompatibility. The terminal complement complex for evaluation and surface modification with heparin for improvement of biomaterials.

  2008cited by this paper
• Heparin bonding of bypass circuits reduces cytokine release during cardiopulmonary bypass.

  1995cited by this paper
• Reduced complement activation and improved postoperative performance after cardiopulmonary bypass with heparin-coated circuits.

  1995cited by this paper
• Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization.

  1994cited by this paper
• Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass.

  1993cited by this paper
• Cytokine and complement levels in patients undergoing cardiopulmonary bypass.

  1993cited by this paper
• Induction of Interleukin‐ 8 Expression During Cardiopulmonary Bypass

  1993cited by this paper
• Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypass.

  1993cited by this paper
• Interleukin-6.

  1993cited by this paper
• Inflammatory response to cardiopulmonary bypass.

  1993cited by this paper
• Elevation of cytokines during open heart surgery with cardiopulmonary bypass: participation of interleukin 8 and 6 in reperfusion injury

  1993cited by this paper
• Cytokine serum level during severe sepsis in human IL-6 as a marker of severity.

  1992cited by this paper
• Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations.

  1992cited by this paper
• Inhibition by dexamethasone of the reperfusion phenomena in cardiopulmonary bypass.

  1991cited by this paper
• Inhibition by dexamethasone of the reperfusion phenomena in cardiopulmonary bypass.

  1991cited by this paper
• Biocompatibility of extracorporeal circulation. In vitro comparison of heparin-coated and uncoated oxygenator circuits.

  1991cited by this paper
• Phagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide 1/interleukin 8

  1991cited by this paper
• Fluid phase generation of terminal complement complex as a novel index of bioincompatibility.

  1990cited by this paper
• Leukocyte depletion ameliorates free radical-mediated lung injury after cardiopulmonary bypass.

  1990cited by this paper
• The Effects of Complement Activation During Cardiopulmonary Bypass: Attenuation by Hypothermia, Heparin, and Hemodilution

  1988cited by this paper
• Human neutrophil degranulation during extracorporeal circulation.

  1987cited by this paper
• Human neutrophil degranulation during extracorporeal circulation

  1987cited by this paper
• Complement and the damaging effects of cardiopulmonary bypass.

  1983cited by this paper
• Heparin prevents formation of the human C3 amplification convertase by inhibiting the binding site for B on C3b.

  1983cited by this paper
• Complement and the damaging effects of cardiopulmonary bypass.

  1983cited by this paper
• Potentiation of factor H by heparin: a rate-limiting mechanism for inhibition of the alternative complement pathway.

  1983cited by this paper

• S100B in cardiac surgery brain monitoring: friend or foe?

  2022cites this paper
• Fluid Management With Peritoneal Dialysis After Pediatric Cardiac Surgery

  2018cites this paper
• ECMO Biocompatibility: Surface Coatings, Anticoagulation, and Coagulation Monitoring

  2016cites this paper
• Biochemical Markers for Brain Injury Monitoring in Children with or without Congenital Heart Diseases.

  2015cites this paper
• Anti-Inflammatory Effects of Heparin and Its Derivatives: A Systematic Review

  2015cites this paper
• Pulmonary Inflammatory Response Pulsatile Pulmonary Perfusion During Cardiopulmonary Bypass Reduces the

  2013cites this paper
• Inhalatives Kohlenmonoxid zur Protektion der Lunge während des kardiopulmonalen Bypasses

  2013cites this paper
• Pulmonary perfusion with L-arginine ameliorates post-cardiopulmonary bypass lung injury in a rabbit model.

  2011cites this paper
• Individualised Heparin and Protamine Sulfate Management in Infants Undergoing Cardiac Surgery with Cardiopulmonary Bypass

  2011cites this paper
• Aus der Universitätsklinik für Thorax-, Herz- und Gefäßchirurgie Tübingen

  2010cites this paper
• PH.D. THESIS THE RESPONSE OF THE LUNGS DURING CARDIAC SURGERY CARRIED OUT ON CARDIOPULMONARY BYPASS

  2009cites this paper
• The Inflammatory Response and Its Modification

  2009cites this paper
• Associations between neurohormonal and inflammatory activation and heart failure in children.

  2008cites this paper
• Pulsatile pulmonary perfusion during cardiopulmonary bypass reduces the pulmonary inflammatory response.

  2008cites this paper
• Heparin-bonded circuits versus nonheparin-bonded circuits: an evaluation of their effect on clinical outcomes.

  2007cites this paper
• Factors influencing neurologic outcome after neonatal cardiopulmonary bypass: what we can and cannot control.

  2006cites this paper
• 15 – Blood flow dynamics and surface interactions

  2005cites this paper
• SELCAB (Self-Lung Cardiac Bypass) Procedures for Pediatric Patients

  2005cites this paper
• Cardiopulmonary bypass and the coagulation system

  2005cites this paper
• Genexpressionsanalysen zur Hämokompatibilität von Fremdoberflächen bei Operationen mit extrakorporaler Zirkulation

  2005cites this paper
• Glucocorticoids reduce cardiac dysfunction after cardiopulmonary bypass and circulatory arrest in neonatal piglets

  2004cites this paper
• Inflammatory response after coronary revascularization: off-pump versus on-pump (heparin-coated circuits and poly2methoxyethylacrylate-coated circuits).

  2004cites this paper
• Influence of two different perfusion systems on inflammatory response in pediatric heart surgery.

  2003cites this paper
• Adsorption of inflammatory cytokines using a heparin-coated extracorporeal circuit.

  2002cites this paper
• Coronary artery bypass surgery with heparin-coated perfusion circuits and low-dose heparinization.

  2002cites this paper
• Strategies for Optimisation of Paediatric Cardiopulmonary Bypass

  2002cites this paper
• Duroflo II heparin bonding does not attenuate cytokine release or improve pulmonary function.

  2002cites this paper
• Evaluation of different paediatric venous cannulae using gravity drainage and VAVD: an in vitro study

  2002cites this paper
• Perianesthesia care of cardiac surgery patients: a CPAN review.

  2001cites this paper
• Platelet activation and aggregation during normothermic cardiopulmonary bypass.

  2001cites this paper
• Inflammation After Cardiopulmonary Bypass: Therapy for the Postpump Syndrome

  2001cites this paper
• Low-dose versus high-dose heparinization during arteriovenous carbon dioxide removal

  2001cites this paper
• [Practice Guidelines of the Spanish Society of Cardiology in the postoperative course of congenital heart diseases].

  2000cites this paper
• Cytokine Mediated Endothelial Activation During and After Normothermic Cardiopulmonary Bypass: Heparin-Bonded versus Non Heparin-Bonded Circuits

  2000cites this paper
• Clinical efficacy of heparin-bonded bypass circuits related to cytokine responses in children.

  2000cites this paper
• Heparin coating of bypass systems.

  2000cites this paper
• Anti-inflammatory pre-treatment and the resultant effects of interleukin-10: adjuncts to multi-therapeutical strategies

  2000cites this paper
• Guías de práctica clínica de la Sociedad Española de Cardiología en el postoperado de cardiopatía congénita

  2000cites this paper
• Do peritoneal catheters remove pro-inflammatory cytokines after cardiopulmonary bypass in neonates?

  2000cites this paper
• Heparin‐Coated Cardiopulmonary Bypass Circuit: Clinical Effects in Pediatric Cardiac Surgery

  2000cites this paper
• Phosphorylcholine coating of extracorporeal circuits provides natural protection against blood activation by the material surface.

  2000cites this paper
• Heparin-coated Cardiopulmonary Bypass Circuits Reduce Circulating Complement Factors and Interleukin-6 in Paediatric Heart Surgery

  2000cites this paper
• Impact of heparin bonding on pediatric cardiopulmonary bypass: a prospective randomized study.

  2000cites this paper
• Recent advances in paediatric cardiopulmonary bypass

  1999cites this paper
• IL-6 and IL-8 levels after cardiopulmonary bypass are not affected by surface coating.

  1999cites this paper
• In vivo evaluation of a phosphorylcholine coated cardiopulmonary bypass circuit.

  1999cites this paper
• Superior biocompatibility of heparin-bonded circuits in pediatric cardiopulmonary bypass.

  1999cites this paper
• Systemic inflammation induced by cardiopulmonary bypass: a review of pathogenesis and treatment.

  1999cites this paper
• Cytokine and S100B levels in paediatric patients undergoing corrective cardiac surgery with or without total circulatory arrest q

  1999cites this paper
• Venovenous modified ultrafiltration after cardiopulmonary bypass in children: a prospective randomized study.

  1999cites this paper
• Cytokine and S100B levels in paediatric patients undergoing corrective cardiac surgery with or without total circulatory arrest.

  1999cites this paper
• Haemocompatibility of paediatric membrane oxygenators with heparin-coated surfaces

  1999cites this paper
• Effect of modified ultrafiltration on plasma thromboxane B2, leukotriene B4, and endothelin-1 in infants undergoing cardiopulmonary bypass.

  1999cites this paper
• Ultrafiltration en chirurgie cardiaque

  1999cites this paper
• Innovative uses of saphenous vein grafts in minimally invasive coronary surgery.

  1998cites this paper
• Reducing inflammatory reactions by heparin-coated circuit.

  1998cites this paper
• Heparin-coated bypass circuits: effects on inflammatory response in pediatric cardiac operations.

  1998cites this paper